Circulating Endothelial Cells and Their Subsets: Novel Biomarkers for Cancer

References

• Folkman J . Tumor angiogenesis: therapeutic implications. N. Engl. J. Med.285(21), 1182–1186 (1971).
   PubMed Web of Science ®Google Scholar
• Hurwitz H , FehrenbacherL, NovotnyWet al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N. Engl. J. Med.350(23), 2335–2342 (2004).
   PubMed Web of Science ®Google Scholar
• Sandler A , GrayR, PerryMCet al. Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer. N. Engl. J. Med.355(24), 2542–2550 (2006).
   PubMed Web of Science ®Google Scholar
• Nishio M , HoraiT, KunitohHet al. Randomized, open-label, multicenter Phase II study of bevacizumab in combination with carboplatin and paclitaxel in chemotherapy-naive Japanese patients with advanced or recurrent nonsquamous non-small cell lung cancer (NSCLC): JO19907. J. Clin. Oncol.27 ( 15 Suppl.), 8036 (2009).
   Google Scholar
• Rini BI . Vascular endothelial growth factor-targeted therapy in renal cell carcinoma: current status and future directions. Clin. Cancer. Res.13(4), 1098–1106 (2007).
   PubMed Web of Science ®Google Scholar
• Khasraw M , AmeratungaMS, GrantR, WheelerH, PavlakisN. Antiangiogenic therapy for high-grade glioma. Cochrane Database Syst. Rev. (9), CD008218 (2014).
   PubMed Web of Science ®Google Scholar
• Strumberg D , ScheulenME, SchultheisBet al. Regorafenib (BAY 73–4506) in advanced colorectal cancer: a Phase I study. Br. J. Cancer106(11), 1722–1727 (2012).
   PubMed Web of Science ®Google Scholar
• Ueda T , UemuraH, TomitaYet al. Efficacy and safety of axitinib versus sorafenib in metastatic renal cell carcinoma: subgroup analysis of Japanese patients from the global randomized Phase 3 AXIS trial. Jpn. J. Clin. Oncol.43(6), 616–628 (2013).
   PubMed Web of Science ®Google Scholar
• Komatsu Y , DoiT, SawakiAet al. Regorafenib for advanced gastrointestinal stromal tumors following imatinib and sunitinib treatment: a subgroup analysis evaluating Japanese patients in the Phase III GRID trial. Int. J. Clin. Oncol.20(5), 905–912 (2015).
   PubMed Web of Science ®Google Scholar
• Bertolini F , ShakedY, MancusoP, KerbelRS. The multifaceted circulating endothelial cell in cancer: towards marker and target identification. Nat. Rev. Cancer6(11), 835–845 (2006).
   PubMed Web of Science ®Google Scholar
• Bertolini F , MancusoP, ShakedY, KerbelRS. Molecular and cellular biomarkers for angiogenesis in clinical oncology. Drug Discov. Today12 (19–20), 806–812 (2007).
   PubMed Web of Science ®Google Scholar
• Hlatky L , HahnfeldtP, FolkmanJ. Clinical application of antiangiogenic therapy: microvessel density, what it does and doesn’t tell us. J. Natl Cancer Inst.94(12), 883–893 (2002).
   PubMedGoogle Scholar
• Hladovec J , RossmannP. Circulatingendothelial cells isolated together with platelets and the experimentalmodification of their counts in rats. Thromb. Res.3, 665–674 (1973).
   Google Scholar
• George F , BrissonC, PonceletPet al. Rapid isolation of human endothelial cells from whole blood using S-Endo1 monoclonal antibody coupled to immuno-magnetic beads: demonstration of endothelial injury after angioplasty. Thromb. Haemost.67(1), 147–153 (1992).
   PubMed Web of Science ®Google Scholar
• Dignat-George F , SampolJ. Circulating endothelial cells in vascular disorders: new insights into an old concept. Eur. J. Haematol.65(4), 215–220 (2000).
   PubMed Web of Science ®Google Scholar
• Goon PK , LipGY, BoosCJ, StonelakePS, BlannAD. Circulating endothelial cells, endothelial progenitor cells, and endothelial microparticles in cancer. Neoplasia8(2), 79–88 (2006).
   PubMed Web of Science ®Google Scholar
• Schmidt DE , MancaM, HoeferIE. Circulating endothelial cells in coronary artery disease and acute coronary syndrome. Trends Cardiovasc. Med.25(7), 578–587 (2015).
   PubMed Web of Science ®Google Scholar
• Zhang K , YinF, LinL. Circulating endothelial cells and chronic kidney disease. Biomed. Res. Int. 2014, 364738 (2014).
   PubMedGoogle Scholar
• Costiniuk CT , HibbertBM, SimardT, GhazawiFM, AngelJB, O’brienER. Circulating endothelial progenitor cells in HIV infection: a systematic review. Trends Cardiovasc. Med.23(6), 192–200 (2013).
   PubMed Web of Science ®Google Scholar
• Mancuso P , BurliniA, PruneriG, GoldhirschA, MartinelliG, BertoliniF. Resting and activated endothelial cells are increased in the peripheral blood of cancer patients. Blood97(11), 3658–3661 (2001).
   PubMed Web of Science ®Google Scholar
• Cines DB , PollakES, BuckCAet al. Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood91(10), 3527–3561 (1998).
   PubMed Web of Science ®Google Scholar
• Hobson B , DenekampJ. Endothelial proliferation in tumours and normal tissues: continuous labelling studies. Br. J. Cancer49(4), 405–413 (1984).
   PubMed Web of Science ®Google Scholar
• Solovey A , LinY, BrowneP, ChoongS, WaynerE, HebbelRP. Circulating activated endothelial cells in sickle cell anemia. N. Engl. J. Med.337(22), 1584–1590 (1997).
   PubMed Web of Science ®Google Scholar
• Moldovan NI , MoldovanL, SimionescuN. Binding of vascular anticoagulant alpha (annexin V) to the aortic intima of the hypercholesterolemic rabbit. An autoradiographic study. Blood Coagul. Fibrinolysis5(6), 921–928 (1994).
   PubMed Web of Science ®Google Scholar
• Lin Y , WeisdorfDJ, SoloveyA, HebbelRP. Origins of circulating endothelial cells and endothelial outgrowth from blood. J. Clin. Invest.105(1), 71–77 (2000).
   PubMed Web of Science ®Google Scholar
• Butthep P , RummavasS, WisedpanichkijR, JindadamrongwechS, FucharoenS, BunyaratvejA. Increased circulating activated endothelial cells, vascular endothelial growth factor, and tumor necrosis factor in thalassemia. Am. J. Hematol.70(2), 100–106 (2002).
   PubMed Web of Science ®Google Scholar
• Goon PK , BoosCJ, LipGY. Circulating endothelial cells: markers of vascular dysfunction. Clin. Lab.51 (9–10), 531–538 (2005).
   PubMed Web of Science ®Google Scholar
• Ruegg C , YilmazA, BielerG, BamatJ, ChaubertP, LejeuneFJ. Evidence for the involvement of endothelial cell integrin alphaVbeta3 in the disruption of the tumor vasculature induced by TNF and IFN-gamma. Nat. Med.4(4), 408–414 (1998).
   PubMed Web of Science ®Google Scholar
• Kirsch T , WoywodtA, BeeseMet al. Engulfment of apoptotic cells by microvascular endothelial cells induces proinflammatory responses. Blood109(7), 2854–2862 (2007).
   PubMed Web of Science ®Google Scholar
• Wang J , XiaoJ, WeiXet al. Circulating endothelial cells and tumor blood volume as predictors in lung cancer. Cancer Sci.104(4), 445–452 (2013).
   PubMed Web of Science ®Google Scholar
• Asahara T , MuroharaT, SullivanAet al. Isolation of putative progenitor endothelial cells for angiogenesis. Science275(5302), 964–967 (1997).
   PubMed Web of Science ®Google Scholar
• Shi Q , RafiiS, WuMHet al. Evidence for circulating bone marrow-derived endothelial cells. Blood92(2), 362–367 (1998).
   PubMed Web of Science ®Google Scholar
• Yoder MC , MeadLE, PraterDet al. Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood109(5), 1801–1809 (2007).
   PubMed Web of Science ®Google Scholar
• Woywodt A , GoldbergC, ScheerJ, RegelsbergerH, HallerH, HaubitzM. An improved assay for enumeration of circulating endothelial cells. Ann. Hematol.83(8), 491–494 (2004).
   PubMed Web of Science ®Google Scholar
• Khan SS , SolomonMA, MccoyJP, Jr. Detection of circulating endothelial cells and endothelial progenitor cells by flow cytometry. Cytometry B Clin. Cytom.64(1), 1–8 (2005).
   PubMedGoogle Scholar
• Woywodt A , BlannAD, KirschTet al. Isolation and enumeration of circulating endothelial cells by immunomagnetic isolation: proposal of a definition and a consensus protocol. J. Thromb. Haemost.4(3), 671–677 (2006).
   PubMed Web of Science ®Google Scholar
• Flores-Nascimento MC , AlessioAM, De Andrade OrsiFL, Annichino-BizzacchiJM. CD144, CD146 and VEGFR-2 properly identify circulating endothelial cell. Rev. Bras. Hematol. Hemoter.37(2), 98–102 (2015).
   PubMedGoogle Scholar
• Solovey AN , GuiL, ChangL, EnensteinJ, BrownePV, HebbelRP. Identification and functional assessment of endothelial P1H12. J. Lab Clin. Med.138(5), 322–331 (2001).
   PubMed Web of Science ®Google Scholar
• Lampugnani MG , ResnatiM, RaiteriMet al. A novel endothelial-specific membrane protein is a marker of cell–cell contacts. J. Cell Biol.118(6), 1511–1522 (1992).
   PubMed Web of Science ®Google Scholar
• Elshal MF , KhanSS, TakahashiY, SolomonMA, MccoyJPJr. CD146 (Mel-CAM), an adhesion marker of endothelial cells, is a novel marker of lymphocyte subset activation in normal peripheral blood. Blood106(8), 2923–2924 (2005).
   PubMed Web of Science ®Google Scholar
• Kim I , YilmazOH, MorrisonSJ. CD144 (VE-cadherin) is transiently expressed by fetal liver hematopoietic stem cells. Blood106(3), 903–905 (2005).
   PubMed Web of Science ®Google Scholar
• Strijbos MH , KraanJ, Den BakkerMA, LambrechtBN, SleijferS, GratamaJW. Cells meeting our immunophenotypic criteria of endothelial cells are large platelets. Cytometry B Clin. Cytom.72(2), 86–93 (2007).
   PubMedGoogle Scholar
• Mancuso P , AntoniottiP, QuarnaJet al. Validation of a standardized method for enumerating circulating endothelial cells and progenitors: flow cytometry and molecular and ultrastructural analyses. Clin. Cancer Res.15(1), 267–273 (2009).
   PubMed Web of Science ®Google Scholar
• Rafii S , LydenD, BenezraR, HattoriK, HeissigB. Vascular and haematopoietic stem cells: novel targets for anti-angiogenesis therapy?Nat. Rev. Cancer2(11), 826–835 (2002).
   PubMed Web of Science ®Google Scholar
• Peichev M , NaiyerAJ, PereiraDet al. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood95(3), 952–958 (2000).
   PubMed Web of Science ®Google Scholar
• Dome B , TimarJ, LadanyiAet al. Circulating endothelial cells, bone marrow-derived endothelial progenitor cells and proangiogenic hematopoietic cells in cancer: from biology to therapy. Crit. Rev. Oncol. Hematol.69(2), 108–124 (2009).
   PubMed Web of Science ®Google Scholar
• Jacques N , VimondN, ConfortiRet al. Quantification of circulating mature endothelial cells using a whole blood four-color flow cytometric assay. J. Immunol. Methods337(2), 132–143 (2008).
   PubMed Web of Science ®Google Scholar
• Lanuti P , SantilliF, MarchisioMet al. A novel flow cytometric approach to distinguish circulating endothelial cells from endothelial microparticles: relevance for the evaluation of endothelial dysfunction. J. Immunol. Methods.380 (1–2), 16–22 (2012).
   PubMed Web of Science ®Google Scholar
• Van Craenenbroeck EM , ConraadsVM, Van BockstaeleDRet al. Quantification of circulating endothelial progenitor cells: a methodological comparison of six flow cytometric approaches. J. Immunol. Methods332 (1–2), 31–40 (2008).
   PubMed Web of Science ®Google Scholar
• Masouleh BK , BaraniskinA, SchmiegelW, SchroersR. Quantification of circulating endothelial progenitor cells in human peripheral blood: establishing a reliable flow cytometry protocol. J. Immunol. Methods357 (1–2), 38–42 (2010).
   PubMed Web of Science ®Google Scholar
• Mariucci S , RovatiB, BencardinoK, ManzoniM, DanovaM. Flow cytometric detection of circulating endothelial cells and endothelial progenitor cells in healthy subjects. Int. J. Lab. Hematol.32 (1 Pt 1), e40–e48 (2010).
   PubMed Web of Science ®Google Scholar
• Van Craenenbroeck EM , Van CraenenbroeckAH, Van IersselSet al. Quantification of circulating CD34+/KDR+/CD45dim endothelial progenitor cells: analytical considerations. Int. J. Cardiol.167(5), 1688–1695 (2013).
   PubMed Web of Science ®Google Scholar
• Ronzoni M , ManzoniM, MariucciSet al. Circulating endothelial cells and endothelial progenitors as predictive markers of clinical response to bevacizumab-based first-line treatment in advanced colorectal cancer patients. Ann. Oncol.21(12), 2382–2389 (2010).
   PubMed Web of Science ®Google Scholar
• Mariucci S , RovatiB, ChatzileontiadouSet al. A six-colour flow cytometric method for simultaneous detection of cell phenotype and apoptosis of circulating endothelial cells. Scand. J. Clin. Lab Invest.69(3), 433–438 (2009).
   PubMed Web of Science ®Google Scholar
• Manzoni M , MariucciS, DelfantiSet al. Circulating endothelial cells and their apoptotic fraction are mutually independent predictive biomarkers in Bevacizumab-based treatment for advanced colorectal cancer. J. Cancer Res. Clin. Oncol.138(7), 1187–1196 (2012).
   PubMed Web of Science ®Google Scholar
• Mancuso P , CalleriA, GregatoGet al. A subpopulation of circulating endothelial cells express CD109 and is enriched in the blood of cancer patients. PLoS ONE9(12), e114713 (2014).
   PubMed Web of Science ®Google Scholar
• Li C , HampsonIN, HampsonL, KumarP, BernabeuC, KumarS. CD105 antagonizes the inhibitory signaling of transforming growth factor beta1 on human vascular endothelial cells. FASEB J.14(1), 55–64 (2000).
   PubMed Web of Science ®Google Scholar
• Osborn L , HessionC, TizardRet al. Direct expression cloning of vascular cell adhesion molecule 1, a cytokine-induced endothelial protein that binds to lymphocytes. Cell59(6), 1203–1211 (1989).
   PubMed Web of Science ®Google Scholar
• Blann AD , WoywodtA, BertoliniFet al. Circulating endothelial cells. Biomarker of vascular disease. Thromb. Haemost.93(2), 228–235 (2005).
   PubMed Web of Science ®Google Scholar
• Widemann A , SabatierF, ArnaudLet al. CD146-based immunomagnetic enrichment followed by multiparameter flow cytometry: a new approach to counting circulating endothelial cells. J. Thromb. Haemost.6(5), 869–876 (2008).
   PubMed Web of Science ®Google Scholar
• Goon PK , BoosCJ, StonelakePS, LipGY. Circulating endothelial cells in malignant disease. Future Oncol.1(6), 813–820 (2005).
   PubMedGoogle Scholar
• Riethdorf S , FritscheH, MullerVet al. Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the CellSearch system. Clin. Cancer Res.13(3), 920–928 (2007).
   PubMed Web of Science ®Google Scholar
• Smirnov DA , FoulkBW, DoyleGV, ConnellyMC, TerstappenLW, O’haraSM. Global gene expression profiling of circulating endothelial cells in patients with metastatic carcinomas. Cancer Res.66(6), 2918–2922 (2006).
   PubMed Web of Science ®Google Scholar
• Rowand JL , MartinG, DoyleGVet al. Endothelial cells in peripheral blood of healthy subjects and patients with metastatic carcinomas. Cytometry A71(2), 105–113 (2007).
   PubMed Web of Science ®Google Scholar
• Cummings J , MorrisK, ZhouCet al. Method validation of circulating tumour cell enumeration at low cell counts. BMC Cancer13, 415 (2013).
   PubMed Web of Science ®Google Scholar
• Ignatiadis M , RiethdorfS, BidardFCet al. International study on inter-reader variability for circulating tumor cells in breast cancer. Breast Cancer Res.16(2), R43 (2014).
   PubMed Web of Science ®Google Scholar
• Simkens LH , TolJ, TerstappenLW, TeerenstraS, PuntCJ, NagtegaalID. The predictive and prognostic value of circulating endothelial cells in advanced colorectal cancer patients receiving first-line chemotherapy and bevacizumab. Ann. Oncol.21(12), 2447–2448 (2010).
   PubMed Web of Science ®Google Scholar
• Matsusaka S , SuenagaM, MishimaYet al. Circulating endothelial cells predict for response to bevacizumab-based chemotherapy in metastatic colorectal cancer. Cancer Chemother. Pharmacol.68(3), 763–768 (2011).
   PubMed Web of Science ®Google Scholar
• Bidard FC , MathiotC, DegeorgesAet al. Clinical value of circulating endothelial cells and circulating tumor cells in metastatic breast cancer patients treated first line with bevacizumab and chemotherapy. Ann. Oncol.21(9), 1765–1771 (2010).
   PubMed Web of Science ®Google Scholar
• Ali AM , UenoT, TanakaSet al. Determining circulating endothelial cells using CellSearch system during preoperative systemic chemotherapy in breast cancer patients. Eur. J. Cancer47(15), 2265–2272 (2011).
   PubMed Web of Science ®Google Scholar
• Goon PK , BoosCJ, StonelakePS, BlannAD, LipGY. Detection and quantification of mature circulating endothelial cells using flow cytometry and immunomagnetic beads: a methodological comparison. Thromb. Haemost.96(1), 45–52 (2006).
   PubMed Web of Science ®Google Scholar
• Kraan J , SleijferS, FoekensJA, GratamaJW. Clinical value of circulating endothelial cell detection in oncology. Drug Discov. Today17 (13–14), 710–717 (2012).
   PubMed Web of Science ®Google Scholar
• Duda DG , CohenKS, ScaddenDT, JainRK. A protocol for phenotypic detection and enumeration of circulating endothelial cells and circulating progenitor cells in human blood. Nat. Protoc.2(4), 805–810 (2007).
   PubMed Web of Science ®Google Scholar
• Willett CG , BoucherY, DudaDGet al. Surrogate markers for antiangiogenic therapy and dose-limiting toxicities for bevacizumab with radiation and chemotherapy: continued experience of a Phase I trial in rectal cancer patients. J. Clin. Oncol.23(31), 8136–8139 (2005).
   PubMed Web of Science ®Google Scholar
• Batchelor TT , SorensenAG, Di TomasoEet al. AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients. Cancer Cell.11(1), 83–95 (2007).
   PubMed Web of Science ®Google Scholar
• Mok TS , WuYL, ThongprasertSet al. Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma. N. Engl. J. Med.361(10), 947–957 (2009).
   PubMed Web of Science ®Google Scholar
• Yeung C , HiltonJ, ClemonsMet al. Estrogen, progesterone, and HER2/neu receptor discordance between primary and metastatic breast tumours-a review. Cancer Metastasis Rev.35(3), 427–437 (2016).
   PubMed Web of Science ®Google Scholar
• Manzoni M , ComolliG, TorchioM, MazziniG, DanovaM. Circulating endothelial cells and their subpopulations: role as predictive biomarkers in antiangiogenic therapy for colorectal cancer. Clin. Colorectal Cancer14(1), 11–17 (2015).
   PubMed Web of Science ®Google Scholar
• Liu Y , YuanD, YeW, LvT, SongY. Prognostic value of circulating endothelial cells in non-small cell lung cancer patients: a systematic review and meta-analysis. Transl. Lung Cancer Res.4(5), 610–618 (2015).
   PubMedGoogle Scholar
• Danova M , ComolliG, ManzoniM, TorchioM, MazziniG. Flow cytometric analysis of circulating endothelial cells and endothelial progenitors for clinical purposes in oncology: a critical evaluation. Mol. Clin. Oncol.4(6), 909–917 (2016).
   PubMedGoogle Scholar
• Kalathil SG , LugadeAA, IyerR, MillerA, ThanavalaY. Endothelial progenitor cell number and ERK phosphorylation serve as predictive and prognostic biomarkers in advanced hepatocellular carcinoma patients treated with sorafenib. Oncoimmunology5(10), e1226718 (2016).
   PubMed Web of Science ®Google Scholar
• St Croix B , RagoC, VelculescuVet al. Genes expressed in human tumor endothelium. Science289(5482), 1197–1202 (2000).
   PubMed Web of Science ®Google Scholar
• Mehran R , NilssonM, KhajaviMet al. Tumor endothelial markers define novel subsets of cancer-specific circulating endothelial cells associated with antitumor efficacy. Cancer Res.74(10), 2731–2741 (2014).
   PubMed Web of Science ®Google Scholar
• Jin H , ChengX, PeiYet al. Identification and verification of transgelin-2 as a potential biomarker of tumor-derived lung-cancer endothelial cells by comparative proteomics. J. Proteomics.136, 77–88 (2016).
   PubMed Web of Science ®Google Scholar
• Maniotis AJ , FolbergR, HessAet al. Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Am. J. Pathol.155(3), 739–752 (1999).
   PubMed Web of Science ®Google Scholar
• Hendrix MJ , SeftorEA, SeftorRE, ChaoJT, ChienDS, ChuYW. Tumor cell vascular mimicry: novel targeting opportunity in melanoma. Pharmacol. Ther.159, 83–92 (2016).
   PubMed Web of Science ®Google Scholar
• Altman DG , McshaneLM, SauerbreiW, TaubeSE. Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): explanation and elaboration. PLoS Med.9(5), e1001216 (2012).
   PubMed Web of Science ®Google Scholar